All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy [Yahoo! Finance]
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress [Yahoo! Finance]
Unity Biotechnology, Inc. (NASDAQ: UBX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates [Yahoo! Finance]
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates